RAB8A a new biomarker for endometrial cancer?

World Journal of Surgical Oncology

Research

Zhenyu Zhang¹  Yachun Bie¹ 

[1] Department of Obstetrics and Gynecology, Beijing Chao-yang Hospital affiliated to Capital Medical University, No. 8 Gongti South Road, 100020, Beijing, China;

关键词: Proteomic analysis;    Dendritic cells (DCs);    Endometrial cancer (EC);    Tumor lysate;    LC-MS/MS;    Biomarker;   

DOI  :  10.1186/1477-7819-12-371

 received in 2014-07-04, accepted in 2014-11-18,  发布年份 2014

来源: Springer

【 摘 要 】

BackgroundWe aimed to find different proteins between dendritic cells (DCs) and tumor antigen-pulsed DCs to help find a new biomarker for endometrial cancer (EC).MethodsMononuclear cells were isolated from cord blood and induced to DCs by cytokines. A comparative proteomic analysis was performed on DCs and tumor lysate-pulsed DCs by liquid chromatography with tandem mass spectrometry (LC-MS/MS). Differential proteins were identified by Western blot analysis.ResultsThe expression of Ras-related protein Rab-8A (RAB8A) was found to be different in the in two kinds of cells. This phenomenon was also proven in endometrial cancer tissues.ConclusionsRAB8A might be a new biomarker for endometrial cancer. Using LC-MS/MS to perform a comparative proteomic analysis about DCs and tumor lysate-pulsed DCs may help us to find new biomarker of cancer.

【 授权许可】

CC BY   
© Bie and Zhang; licensee BioMed Central. 2014